Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved.

Abstract

Abstract available in pdf.

Description

CAPRISA, 2014.

Citation

Wiehe, K., Easterhoff, D., Luo, K., Nicely, N.I., Bradley, T., Jaeger, F.H., Dennison, S.M., Zhang, R., Lloyd, K.E., Stolarchuk, C.,Parks, R., Sutherland, L.L., Scearce, R.M., Morris, L., Kaewkungwal, J., Nitayaphan, S., Pitisuttithum, P., Rerks-Ngarm, S., Sinangil, F., Phogat, S., Michael, N.L., Kim, J.H., Kelsoe, G., Montefiori, D.C., Tomaras, G.D., Bonsignori, M., Santra, S., Kepler, T.B., Alam, S.M., Moody, M.A., Liao, H.X., and Haynes, B.F. 2014. Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved. Immunity 41(6), 909-918.

Endorsement

Review

Supplemented By

Referenced By